CoChat
Cited by 48

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Targeting Raf Kinase Inhibitory Protein Regulation and Function

Yesilkanal, Ali Ekrem, Rosner, Marsha Rich · 2018 · Cancers

Abstract

Raf Kinase Inhibitory Protein (RKIP) is a highly conserved kinase inhibitor that functions as a metastasis suppressor in a variety of cancers. Since RKIP can reprogram tumor cells to a non-metastatic state by rewiring kinase networks, elucidating the mechanism by which RKIP acts not only reveals molecular mechanisms that regulate metastasis, but also represents an opportunity to target these signaling networks therapeutically. Although RKIP is often lost during metastatic progression, the mechanism by which this occurs in tumor cells is complex and not well understood. In this review, we summarize our current understanding of RKIP regulation in tumors and consider experimental and computational strategies for recovering or mimicking its function by targeting mediators of metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers10090306

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 70

  1. Lamiman, 2014, Survey of Raf kinase inhibitor protein (RKIP) in multiple cancer types, Crit. Rev. Oncog., 19, 455, 10.1615/CritRevOncog.2014011987 · DOI
  2. Martinho, O., Granja, S., Jaraquemada, T., Caeiro, C., Miranda-Gonçalves, V., Honavar, M., Costa, P., Damasceno, M., Rosner, M.R., and Lopes, J.M. (2012). Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas. PLoS ONE, 7. · doi:10.1371/journal.pone.0030769
  3. Martinho, O., Pinto, F., Granja, S., Miranda-Gonçalves, V., Moreira, M.A.R., Ribeiro, L.F.J., di Loreto, C., Rosner, M.R., Longatto-Filho, A., and Reis, R.M. (2013). RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy. PLoS ONE, 8. · doi:10.1371/journal.pone.0059104
  4. Yun, 2009, Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7, EMBO J., 28, 347, 10.1038/emboj.2008.294 · DOI · Paper page
  5. Fu, 2003, Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis, J. Natl. Cancer Inst., 95, 878, 10.1093/jnci/95.12.878 · DOI · Paper page
  6. Bainer, 2016, Gene expression in local stroma reflects breast tumor states and predicts patient outcome, Sci. Rep., 6, e39240, 10.1038/srep39240 · DOI
  7. Frankenberger, 2015, Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages, Cancer Res., 75, 4063, 10.1158/0008-5472.CAN-14-3394 · DOI
  8. Lee, U., Frankenberger, C., Yun, J., Bevilacqua, E., Caldas, C., Chin, S.-F., Rueda, O.M., Reinitz, J., and Rosner, M.R. (2013). A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients. PLoS ONE, 8. · DOI
  9. Sun, 2013, HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis, Proc. Natl. Acad. Sci. USA, 110, 9920, 10.1073/pnas.1305172110 · DOI · Paper page
  10. Yun, 2011, Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer, EMBO J., 30, 4500, 10.1038/emboj.2011.312 · DOI · Paper page
  11. Yeung, 1999, Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP, Nature, 401, 173, 10.1038/43686 · DOI · Paper page
  12. Yesilkanal, 2014, Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: Regulation of signaling networks in cancer, Crit. Rev. Oncog., 19, 447, 10.1615/CritRevOncog.2014012000 · DOI
  13. Zhao, 2014, Interactions of RKIP with inflammatory signaling pathways, Crit. Rev. Oncog., 19, 497, 10.1615/CritRevOncog.2014011950 · DOI
  14. Lorenz, 2003, Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2, Nature, 426, 574, 10.1038/nature02158 · DOI · Paper page
  15. Skinner, 2014, RKIP Structure Drives Its Function: A Three-State Model for Regulation of RKIP, Crit. Rev. Oncog., 19, 483, 10.1615/CritRevOncog.2014012001 · DOI · Paper page
  16. Skinner, 2017, Conserved salt-bridge competition triggered by phosphorylation regulates the protein interactome, Proc. Natl. Acad. Sci. USA., 114, 13453, 10.1073/pnas.1711543114 · DOI · Paper page
  17. Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal., 6, pl1, 10.1126/scisignal.2004088 · DOI · Paper page
  18. Guo, 2013, Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma, Clin. Exp. Metastasis, 30, 265, 10.1007/s10585-012-9533-x · doi:10.1007/s10585-012-9533-x
  19. LI, 2014, Promoter methylation of Raf kinase inhibitory protein: A significant prognostic indicator for patients with gastric adenocarcinoma, Exp. Ther. Med., 8, 844, 10.3892/etm.2014.1833 · doi:10.3892/etm.2014.1833
  20. Guo, 2012, Decreased expression and aberrant methylation of Raf kinase inhibitory protein gene in esophageal squamous cell carcinoma, Cancer Investig., 30, 703, 10.3109/07357907.2012.732164 · doi:10.3109/07357907.2012.732164
  21. Wei, 2017, Promoter methylation and expression of Raf kinase inhibitory protein in esophageal squamous cell carcinoma, Oncol. Lett., 13, 1866, 10.3892/ol.2017.5617 · doi:10.3892/ol.2017.5617
  22. Hagan, 2008, Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability, J. Clin. Pathol., 61, 524, 10.1136/jcp.2007.046987 · doi:10.1136/jcp.2007.046987
  23. Minoo, 2006, Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis, Gut., 55, 1467, 10.1136/gut.2005.082859 · DOI
  24. Kim, 2017, Reduced RKIP Expression is Associated with Breast Neoplastic Progression and is Correlated with Poor Outcomes and Aberrant Methylation in Breast Carcinoma, Appl. Immunohistochem. Mol. Morphol. AIMM, 25, 467
  25. Beach, 2008, Snail is a repressor of RKIP transcription in metastatic prostate cancer cells, Oncogene, 27, 2243, 10.1038/sj.onc.1210860 · DOI · Paper page
  26. Labbozzetta, 2015, Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cells, Oncol. Lett., 10, 3807, 10.3892/ol.2015.3787 · doi:10.3892/ol.2015.3787
  27. Lee, 2014, Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions, Proc. Natl. Acad. Sci. USA, 111, 364
  28. Ren, 2012, Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer, Cancer Res., 72, 3091, 10.1158/0008-5472.CAN-11-3546 · DOI · Paper page
  29. Bonavida, 2011, Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry, Nitric Oxide Biol. Chem., 24, 1, 10.1016/j.niox.2010.10.001 · DOI
  30. Das, 2012, Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma, Cancer Res., 72, 6217, 10.1158/0008-5472.CAN-12-0402 · doi:10.1158/0008-5472.can-12-0402
  31. Liang, 2012, Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis, J. Biol. Chem., 287, 33533, 10.1074/jbc.M112.392332 · DOI
  32. Zhang, 2012, Transcriptional regulation of RKIP expression by androgen in prostate cells, Cell Physiol. Biochem. Int. J. Exp. Cell Physiol. Biochem. Pharmacol., 30, 1340, 10.1159/000343323 · doi:10.1159/000343323
  33. Zhang, B., Wang, O., Qin, J., Liu, S., Sun, S., Liu, H., Kuang, J., Jiang, G., and Zhang, W. (2013). cis-Acting elements and trans-acting factors in the transcriptional regulation of raf kinase inhibitory protein expression. PLoS ONE, 8. · DOI
  34. Li, 2014, miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells, Mol. Cancer, 13, e193, 10.1186/1476-4598-13-193 · DOI
  35. Du, 2017, MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP, Cell Physiol. Biochem. Int. J. Exp. Cell Physiol. Biochem. Pharmacol., 41, 1135, 10.1159/000464120 · DOI
  36. Du, 2017, LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression, Oncotarget, 8, 94358, 10.18632/oncotarget.21719 · DOI
  37. Hatzl, 2016, Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP, Cancer Res., 76, 3644, 10.1158/0008-5472.CAN-15-3049 · DOI
  38. Huang, 2012, MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells, Biochem. Biophys. Res. Commun., 425, 127, 10.1016/j.bbrc.2012.07.025 · DOI
  39. Poma, 2012, Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma, Omics J. Integr. Biol., 16, 579, 10.1089/omi.2012.0048 · DOI
  40. Kim, 2018, Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines, J. Cancer Res. Clin. Oncol., 144, 1487, 10.1007/s00432-018-2672-y · doi:10.1007/s00432-018-2672-y
  41. Moen, E.L., Wen, S., Anwar, T., Cross-Knorr, S., Brilliant, K., Birnbaum, F., Rahaman, S., Sedivy, J.M., Moss, S.F., and Chatterjee, D. (2012). Regulation of RKIP function by Helicobacter pylori in gastric cancer. PLoS ONE, 7. · DOI
  42. Wen, 2014, CDK5-mediated phosphorylation and autophagy of RKIP regulate neuronal death in Parkinson’s disease, Neurobiol. Aging, 35, 2870, 10.1016/j.neurobiolaging.2014.05.034 · DOI · Paper page
  43. Baritaki, 2010, Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: Inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP, Cell Cycle, 9, 4931, 10.4161/cc.9.24.14229 · DOI
  44. Tsao, 2009, Nitric oxide enhances expression of raf kinase inhibitor protein in keratinocytes, Exp. Dermatol., 18, 571, 10.1111/j.1600-0625.2008.00811.x · DOI
  45. Pasqualetti, 2011, Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines, Lung Cancer Amst. Neth., 74, 197, 10.1016/j.lungcan.2011.03.003 · DOI
  46. Ricciardi, 2010, Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells, Chemotherapy, 56, 303, 10.1159/000320031 · doi:10.1159/000320031
  47. Giovannetti, 2013, Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells, Curr. Pharm. Des., 19, 927, 10.2174/138161213804547268 · doi:10.2174/138161213804547268
  48. Chatterjee, 2004, RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis, J. Biol. Chem., 279, 17515, 10.1074/jbc.M313816200 · doi:10.1074/jbc.m313816200
  49. Yousuf, S., Duan, M., Moen, E.L., Cross-Knorr, S., Brilliant, K., Bonavida, B., LaValle, T., Yeung, K.C., Al-Mulla, F., and Chin, E. (2014). Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer. PLoS ONE, 9. · DOI
  50. Chen, 2014, Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells, J. Mol. Med. Berl. Ger., 92, 53, 10.1007/s00109-013-1083-4 · doi:10.1007/s00109-013-1083-4
  51. Beshir, 2011, Locostatin Disrupts Association of Raf Kinase Inhibitor Protein with Binding Proteins by Modifying a Conserved Histidine Residue in the Ligand-Binding Pocket, Forum Immunopathol. Dis. Ther., 2, 47, 10.1615/ForumImmunDisTher.v2.i1.60 · doi:10.1615/forumimmundisther.v2.i1.60
  52. Zhu, 2005, A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration, Chem. Biol., 12, 981, 10.1016/j.chembiol.2005.07.007 · DOI
  53. Shemon, A.N., Eves, E.M., Clark, M.C., Heil, G., Granovsky, A., Zeng, L., Imamoto, A., Koide, S., and Rosner, M.R. (2009). Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration. PLoS ONE, 4. · doi:10.1371/journal.pone.0006028
  54. Zebisch, 2012, Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia, Leukemia, 26, 1842, 10.1038/leu.2012.61 · DOI
  55. Caraffini, 2018, Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration, Blood, 131, 826, 10.1182/blood-2017-09-804906 · doi:10.1182/blood-2017-09-804906
  56. Stahl, M., Kohrman, N., Gore, S.D., Kim, T.K., Zeidan, A.M., and Prebet, T. (2016). Epigenetics in Cancer: A Hematological Perspective. PLoS Genet., 12. · DOI
  57. Huang, 2013, TET1 plays an essential oncogenic role in MLL-rearranged leukemia, Proc. Natl. Acad. Sci. USA., 110, 11994, 10.1073/pnas.1310656110 · DOI · Paper page
  58. Baritaki, 2011, Unique Pattern of Overexpression of Raf-1 Kinase Inhibitory Protein in Its Inactivated Phosphorylated Form in Human Multiple Myeloma, Forum Immunopathol. Dis. Ther., 2, 179, 10.1615/ForumImmunDisTher.v2.i2.90 · doi:10.1615/forumimmundisther.v2.i2.90
  59. Jazirehi, 2004, Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin’s lymphoma B cells by Rituximab, Cancer Res., 64, 7117, 10.1158/0008-5472.CAN-03-3500 · DOI · Paper page
  60. Vega, 2009, Dysregulation of the cell survival/anti-apoptotic NF-κB pathway by the novel humanized BM-ca anti-CD20 mAb: Implication in chemosensitization, Int. J. Oncol., 35, 1289, 10.3892/ijo_00000446 · DOI
  61. Baritaki, 2011, The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: Role in sensitization to TRAIL apoptosis, Int. J. Oncol., 38, 1683
  62. Trakul, 2005, Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation, J. Biol. Chem., 280, 24931, 10.1074/jbc.M413929200 · DOI · Paper page
  63. Yeung, 2000, Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein, Mol. Cell. Biol., 20, 3079, 10.1128/MCB.20.9.3079-3085.2000 · DOI · Paper page
  64. Yeung, 2001, Raf kinase inhibitor protein interacts with NF-κB-inducing kinase and TAK1 and inhibits NF-κB activation, Mol. Cell. Biol., 21, 7207, 10.1128/MCB.21.21.7207-7217.2001 · DOI · Paper page
  65. Grimaldi, 2017, MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid Tumors, Am. J. Clin. Dermatol., 18, 745, 10.1007/s40257-017-0292-y · DOI
  66. Battula, 2017, IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells, Oncotarget, 8, 36936, 10.18632/oncotarget.16294 · DOI
  67. Andela, 2000, Tumor Metastasis and the Reciprocal Regulation of Prometastatic and Antimetastatic Factors by Nuclear Factor κB, Cancer Res., 60, 6557
  68. Golubovskaya, 2014, Targeting FAK in human cancer: From finding to first clinical trials, Front. Biosci. Landmark Ed., 19, 687, 10.2741/4236 · DOI · Paper page
  69. Noy, 2014, Tumor-associated macrophages: From mechanisms to therapy, Immunity, 41, 49, 10.1016/j.immuni.2014.06.010 · DOI · Paper page
  70. Ideker, 2011, Boosting signal-to-noise in complex biology: Prior knowledge is power, Cell, 144, 860, 10.1016/j.cell.2011.03.007 · DOI · Paper page

Cited by

See all 48

Metadata

Authors
Yesilkanal, A. E., & Rosner, M. R.
Affiliations
Ben May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA
Venue
Cancers
Publisher
MDPI AG
Published
2018-09-04
Volume
10
Issue
9
Pages
306
ISSN
2072-6694
Cited by
48
References
2
Language
en
Funders
National Institutes of Health (R01CA184494, R01GM121735)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting Raf Kinase Inhibitory Protein Regulation and Function. https://app.cochat.ai/papers/10.3390/cancers10090306
The paper
Yesilkanal, A. E., & Rosner, M. R. (2018). Targeting Raf Kinase Inhibitory Protein Regulation and Function. Cancers. https://doi.org/10.3390/cancers10090306

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.